Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-5-4
|
pubmed:abstractText |
An interleukin-2 (IL-2) in vitro reduced production has been observed in most metastatic cancer patients. At present, however, there are no data on blood IL-2 levels in vivo, because of the too low sensitivity of previous biological and enzyme immunoassay methods. The recent development of a sensitive RIA method allowed us to start a preliminary investigation of IL-2 production in basal conditions in human solid tumors. The study included 42 cancer patients. Breast and lung cancer were the two commonest neoplasms. Serum levels of IL-2 and soluble IL-2 receptors (SIL-2R), and CD4/CD8 ratio were measured in each patient. The control group consisted of 58 healthy subjects. Mean serum levels of IL-2 were significantly lower in metastatic patients (n = 23) than in those without metastases (n = 19). Patients with low CD4/CD8 ratio (n = 16) had significantly lower mean values of IL-2 than those with normal ratio (n = 26). Finally, mean IL-2 concentrations were significantly lower in patients with elevated levels of SIL-2R than in those with normal values. These results would suggest that metastatic dissemination is associated with a decreased IL-2 production in vivo, and that reduced IL-2 production is more frequent in patients with low CD4/CD8 ratio.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-8916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-7
|
pubmed:dateRevised |
2008-12-12
|
pubmed:meshHeading |
pubmed-meshheading:2108515-Antigens, CD4,
pubmed-meshheading:2108515-Antigens, CD8,
pubmed-meshheading:2108515-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:2108515-Autoimmune Diseases,
pubmed-meshheading:2108515-Female,
pubmed-meshheading:2108515-Humans,
pubmed-meshheading:2108515-Interleukin-2,
pubmed-meshheading:2108515-Male,
pubmed-meshheading:2108515-Middle Aged,
pubmed-meshheading:2108515-Neoplasms,
pubmed-meshheading:2108515-Receptors, Interleukin-2,
pubmed-meshheading:2108515-T-Lymphocytes
|
pubmed:year |
1990
|
pubmed:articleTitle |
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patients.
|
pubmed:affiliation |
Divisione di Radioterapia Oncologica, Ospedale San Gerardo, Monza, Milano, Italy.
|
pubmed:publicationType |
Journal Article
|